Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.05), $0.22 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $16.96 million versus the consensus estimate of $18 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.